Telehealth as effective as personal contact 14/02/2022 No Comments Results from an American study of more than 2,200 people with Type 1 diabetes and their caregivers, showed a majority of those who opted for Read More »
DEPICT-1 results 06/12/2017 No Comments The 24-week results from a trial, DEPICT-1, people with Type 1 diabetes taking the oral selective SGLT-2 inhibitor class of diabetes medicines show that dapagliflozin, Read More »